Boston, MA, United States of America

Ehsan Azimi

This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ehsan Azimi. Retrieved from https://idiyas.com/inventor/ehsan-azimi-po292n3z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ehsan Azimi: Innovator in Itch Treatment

Introduction

Ehsan Azimi is a notable inventor based in Boston, MA, who has made significant contributions to the field of dermatology. His work primarily focuses on the prevention and treatment of itch, a common yet often debilitating condition.

Latest Patents

Ehsan Azimi holds 1 patent for his innovative approach to treating itch. His patent, titled "Prevention and treatment of itch with an MRGPR antagonist," describes compositions and methods that utilize a therapeutically effective amount of a MRG receptor antagonist, such as a tripeptide QWF. This invention is particularly relevant for addressing non-histamine mediated itch, providing new avenues for relief.

Career Highlights

Ehsan Azimi is affiliated with The General Hospital Corporation, where he applies his expertise in developing therapeutic solutions. His work has the potential to improve the quality of life for many individuals suffering from chronic itch conditions.

Collaborations

Throughout his career, Ehsan has collaborated with esteemed colleagues, including Ethan A Lerner and Vemuri B Reddy. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ehsan Azimi's contributions to itch treatment through his patented methods highlight his role as a key innovator in the medical field. His work not only advances scientific understanding but also offers hope for effective treatments for those affected by itch.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…